Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

SLE: reconciling heterogeneity.

Lockshin MD, Barbhaiya M, Izmirly P, Buyon JP, Crow MK.

Lupus Sci Med. 2019 Feb 4;6(1):e000280. doi: 10.1136/lupus-2018-000280. eCollection 2019. No abstract available.

2.

To Eat the Elephant.

Lockshin MD.

Arthritis Rheumatol. 2019 Feb;71(2):177-178. doi: 10.1002/art.40761. No abstract available.

PMID:
30346107
3.

Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus.

Kozora E, Filley CM, Erkan D, Uluğ AM, Vo A, Ramon G, Burleson A, Zimmerman RD, Lockshin MD.

Lupus. 2018 Oct;27(11):1810-1818. doi: 10.1177/0961203318793215. Epub 2018 Aug 13.

PMID:
30103647
4.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

5.

Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.

Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):230-235. doi: 10.1002/acr.23263. Epub 2017 Dec 29.

6.

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

7.

American College of Rheumatology Criteria for Systemic Lupus Erythematosus Exclude Half of All Systemic Lupus Erythematosus Patients.

Jia L, Levine AB, Lockshin MD.

Arthritis Rheumatol. 2017 Jul;69(7):1502-1503. doi: 10.1002/art.40120. Epub 2017 May 10. No abstract available.

8.

Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients.

Kozora E, Uluğ AM, Erkan D, Vo A, Filley CM, Ramon G, Burleson A, Zimmerman R, Lockshin MD.

Arthritis Care Res (Hoboken). 2016 Nov;68(11):1655-1663. doi: 10.1002/acr.22873.

9.

Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.

Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE.

Arthritis Rheumatol. 2016 Aug;68(8):1964-9. doi: 10.1002/art.39668.

10.

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.

Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE.

Lupus Sci Med. 2016 Jan 12;3(1):e000131. doi: 10.1136/lupus-2015-000131. eCollection 2016.

11.

Mitral Valve Vegetation in Antiphospholipid Syndrome.

Unlu O, Lieber SB, Roman MJ, Erkan D, Lockshin MD.

Arthritis Rheumatol. 2016 May;68(5):1300. doi: 10.1002/art.39598. No abstract available.

12.

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.

Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.

Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29.

13.

Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE.

Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235.

14.

Patients with overlap autoimmune disease differ from those with 'pure' disease.

Lockshin MD, Levine AB, Erkan D.

Lupus Sci Med. 2015 May 6;2(1):e000084. doi: 10.1136/lupus-2015-000084. eCollection 2015.

15.

"David Seegal".

Lockshin MD.

Pharos Alpha Omega Alpha Honor Med Soc. 2015 Winter;78(1):59. No abstract available.

PMID:
25796666
16.

Lupus science and medicine: dialogue.

Sammaritano LR, Lockshin MD.

Lupus Sci Med. 2014 Jul 22;1(1):e000048. doi: 10.1136/lupus-2014-000048. eCollection 2014. No abstract available. Erratum in: Lupus Sci Med. 2014;1(1). pii: lupus-2014-000048corr1. doi: 10.1136/lupus-2014-000048corr1.

17.

Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Karadeniz A, Lally L, Magro C, Levy R, Erkan D, Lockshin MD.

HSS J. 2014 Oct;10(3):286-91. doi: 10.1007/s11420-014-9405-9. Epub 2014 Aug 27. No abstract available.

18.

Assisted reproductive technology in SLE and APS.

Levine AB, Lockshin MD.

Lupus. 2014 Oct;23(12):1239-41. doi: 10.1177/0961203314527370.

PMID:
25228714
19.

Perioperative management of antiphospholipid antibody-positive patients.

Saunders KH, Erkan D, Lockshin MD.

Curr Rheumatol Rep. 2014 Jul;16(7):426. doi: 10.1007/s11926-014-0426-7. Review.

PMID:
24828479
20.

Therapy: Antiphospholipid syndrome research needs more collaboration.

Erkan D, Lockshin MD.

Nat Rev Rheumatol. 2014 May;10(5):266-7. doi: 10.1038/nrrheum.2014.39. Epub 2014 Mar 11. No abstract available.

PMID:
24614590
21.

14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.

Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, Levy RA, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Willis R, Lockshin MD.

Autoimmun Rev. 2014 Jun;13(6):685-96. doi: 10.1016/j.autrev.2014.01.053. Epub 2014 Jan 24. Review.

PMID:
24468415
22.

Splitting headache (off).

Lockshin MD.

Arthritis Rheum. 2013 Nov;65(11):2759-61. doi: 10.1002/art.38108. No abstract available.

23.

Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.

Kozora E, Erkan D, Zhang L, Zimmerman R, Ramon G, Ulug AM, Lockshin MD.

Clin Exp Rheumatol. 2014 Jan-Feb;32(1):34-40. Epub 2013 Sep 10.

PMID:
24021640
24.

Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.

Lockshin MD.

Clin Lab Med. 2013 Jun;33(2):367-76. doi: 10.1016/j.cll.2013.01.001. Epub 2013 Apr 19. Review.

25.

Reply: To PMID 23044629.

Lockshin MD, Cohn E, Aslam A, Buyon JP, Salmon JE.

Arthritis Rheum. 2013 Apr;65(4):1129-30. doi: 10.1002/art.37851. No abstract available.

26.

Pregnancy and antiphospholipid syndrome.

Lockshin MD.

Am J Reprod Immunol. 2013 Jun;69(6):585-7. doi: 10.1111/aji.12071. Epub 2012 Dec 28. Review.

PMID:
23279134
27.

Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE).

Kozora E, Erkan D, West SG, Filley CM, Zhang L, Ramon G, Duggan E, Lockshin MD.

Lupus. 2013 Jan;22(1):73-80. doi: 10.1177/0961203312468963.

PMID:
23263866
28.

A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome.

Erkan D, Vega J, Ramón G, Kozora E, Lockshin MD.

Arthritis Rheum. 2013 Feb;65(2):464-71. doi: 10.1002/art.37759.

29.

Cognitive or cosmetic dysfunction?

Uludag O, Erkan D, Lockshin MD.

Arthritis Rheum. 2012 Dec;64(12):4134. doi: 10.1002/art.37694. No abstract available.

30.

Antiphospholipid: to test, or not to test, that is the question.

Lockshin MD.

Int J Clin Pract. 2012 Jul;66(7):620-1. doi: 10.1111/j.1742-1241.2012.02892.x. No abstract available.

PMID:
22698413
31.

APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking.

Erkan D, Lockshin MD; APS ACTION members.

Lupus. 2012 Jun;21(7):695-8. doi: 10.1177/0961203312437810.

32.

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter TF, Sammaritano L, Stephenson MD, Buyon J, Salmon JE.

Arthritis Rheum. 2012 Jul;64(7):2311-8. doi: 10.1002/art.34402.

33.

Are posttranslational modifications of β2-glycoprotein I markers for thrombotic risk? Are they triggers of autoimmunity?

Lockshin MD, Salmon JE.

Arthritis Rheum. 2011 Sep;63(9):2558-60. doi: 10.1002/art.30382. No abstract available.

34.

Antiphospholipid Syndrome Clinical Research Task Force report.

Erkan D, Derksen R, Levy R, Machin S, Ortel T, Pierangeli S, Roubey R, Lockshin M.

Lupus. 2011 Feb;20(2):219-24. doi: 10.1177/0961203310395053.

PMID:
21303838
35.

Pregnancy and reproduction in autoimmune rheumatic diseases.

Ostensen M, Brucato A, Carp H, Chambers C, Dolhain RJ, Doria A, Förger F, Gordon C, Hahn S, Khamashta M, Lockshin MD, Matucci-Cerinic M, Meroni P, Nelson JL, Parke A, Petri M, Raio L, Ruiz-Irastorza G, Silva CA, Tincani A, Villiger PM, Wunder D, Cutolo M.

Rheumatology (Oxford). 2011 Apr;50(4):657-64. doi: 10.1093/rheumatology/keq350. Epub 2010 Nov 18. Review.

36.

Medical publishing. Will paper live on?

Lockshin MD.

Pharos Alpha Omega Alpha Honor Med Soc. 2010 Summer;73(3):4-7. No abstract available.

PMID:
20695104
37.

Transition.

Lockshin MD.

Arthritis Rheum. 2010 Jun;62(6):1564. doi: 10.1002/art.27479. No abstract available.

38.

Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.

Erkan D, Kozora E, Lockshin MD.

Pathophysiology. 2011 Feb;18(1):93-102. doi: 10.1016/j.pathophys.2010.04.010. Epub 2010 May 15.

PMID:
20472406
39.

Nonhormonal explanations for sex discrepancy in human illness.

Lockshin MD.

Ann N Y Acad Sci. 2010 Apr;1193:22-4. doi: 10.1111/j.1749-6632.2009.05293.x. Review.

PMID:
20398003
40.

Non-criteria manifestations of antiphospholipid syndrome.

Erkan D, Lockshin MD.

Lupus. 2010 Apr;19(4):424-7. doi: 10.1177/0961203309360545.

PMID:
20353981
41.

Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.

Perna M, Roman MJ, Alpert DR, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Cooke JP, Salmon JE.

Arthritis Rheum. 2010 Jun;62(6):1718-22. doi: 10.1002/art.27392.

42.

Clinical trial registration and publication of randomized controlled trials.

Lockshin MD, Katz PP, Yelin EH.

JAMA. 2010 Feb 10;303(6):517-8; author reply 518. doi: 10.1001/jama.2010.95. No abstract available.

PMID:
20145227
43.

Statins for the treatment of obstetric complications in antiphospholipid syndrome?

Lockshin MD, Pierangeli SS.

J Reprod Immunol. 2010 Mar;84(2):206; author reply 206-7. doi: 10.1016/j.jri.2009.11.007. Epub 2010 Feb 4. No abstract available.

PMID:
20132990
44.

The child, grown, becomes independent.

Katz PP, Yelin EH, Lockshin MD.

Arthritis Rheum. 2009 Dec;60(12):3523. doi: 10.1002/art.25083. No abstract available.

45.
46.

New approaches for managing antiphospholipid syndrome.

Erkan D, Lockshin MD.

Nat Clin Pract Rheumatol. 2009 Mar;5(3):160-70. doi: 10.1038/ncprheum1017. Review.

PMID:
19252521
47.

Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction.

Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, Crow MK, Sammaritano L, Levine DM, Salmon JE.

Arthritis Rheum. 2009 Jan;60(1):22-9. doi: 10.1002/art.24148.

48.

Catastrophic antiphospholipid syndrome triggered by sepsis.

Kim S, Moskowitz NK, DiCarlo EF, Bass AR, Erkan D, Lockshin MD.

HSS J. 2009 Feb;5(1):67-72. doi: 10.1007/s11420-008-9103-6. Epub 2008 Dec 19. No abstract available.

49.

Update on antiphospholipid syndrome.

Lockshin MD.

Bull NYU Hosp Jt Dis. 2008;66(3):195-7. Review.

50.

Primary antiphospholipid syndrome presenting as HELLP syndrome: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery.

George D, Vasanth L, Erkan D, Bass A, Salmon J, Lockshin MD.

HSS J. 2007 Sep;3(2):216-21. doi: 10.1007/s11420-007-9043-6. Epub 2007 Apr 26. No abstract available.

Supplemental Content

Loading ...
Support Center